Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8<sup>+</sup>CD69<sup>+</sup> T cells

This study demonstrated that NPT-gels combined with PCDB could exert a durable and powerful antitumor immunity by enhancing the recruitment and activation of CD8<sup>+</sup>CD69<sup>+</sup> T cells, which supports the rationale and clinical translation of this combination strategy and provides important evidence for further improving the immunotherapy efficacy of liver metastases in the future.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2024-12-01
DOI
https://doi.org/10.1136/jitc-2024-009543
Citations
12
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
2.89

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8+CD69+ T cells

Aimin Ge, Huan Yang, Shichuan Tang, Ruijing Tang et al.
12 citations
Journal for ImmunoTherapy of Cancer
Immunotherapy and Immune Responses
2.89
article

Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8+CD69+ T cells

Aimin Ge, Huan Yang, Shichuan Tang, Ruijing Tang, Yongyi Zeng, Tingfeng Huang, Ming Wu, Jun Fu, Qizhu Lin, Xiaowei Yin, Kongying Lin, Xiaolong Liu, Geng Chen, Da Zhang, Xiuqing Dong, Yutong Guo, Zhixiong Cai, Jie Kong, Fangzhou Lin
article en
12 citations

Abstract

This study demonstrated that NPT-gels combined with PCDB could exert a durable and powerful antitumor immunity by enhancing the recruitment and activation of CD8<sup>+</sup>CD69<sup>+</sup> T cells, which supports the rationale and clinical translation of this combination strategy and provides important evidence for further improving the immunotherapy efficacy of liver metastases in the future.

Journal for ImmunoTherapy of CancerVol. 12(12)
Fujian Medical University (CN), Xian Central Hospital (CN), Mengchao Hepatobiliary Hospital (CN), First Affiliated Hospital of Fujian Medical University (CN), Heze Municipal Hospital (CN)
National Natural Science Foundation of China
No poverty
Openalex Percentile: Top 8%
Immunotherapy and Immune Responses
2.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.